Spironolactone and hydrochlorothiazide

Product NDC
72888-040
Requested package NDC
72888-040-01
11-digit product format
728880040
Labeler code
72888
Product ID
72888-040_5b333a2a-14ce-8106-e063-6394a90aff6c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Spironolactone and hydrochlorothiazide
Dosage form
TABLET
Route
ORAL
Labeler
Advagen Pharma Ltd.
Application
ANDA220884
Marketing category
ANDA
Marketing start
2026-09-10
Substance
SPIRONOLACTONE; HYDROCHLOROTHIAZIDE
Active strength
25; 25 mg/1; mg/1
Pharmacologic classes
Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A220884-001SPIRONOLACTONE AND HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; SPIRONOLACTONE25MG;25MGTABLET / ORALAB2026-09-10

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A220884-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A220884-001SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGTABLET / ORALAB2026-09-10d4dbc9d85df4…
2026-10-15 13:18:302026-09A220884-001SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGTABLET / ORALAB2026-09-10c2088c7a36db…
2026-09-14 22:38:342026-08A220884-001SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE25MG;25MGTABLET / ORALAB2026-09-1084e616aacf4f…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A220884-001AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A220884-001AB1c2088c7a36db…
2026-09-14 22:38:342026-08A220884-001AB184e616aacf4f…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Spironolactone and hydrochlorothiazide
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SPIRONOLACTONE25 mg/1
HYDROCHLOROTHIAZIDE25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
27O7W4T232Internal UNII lookup
0J48LPH2THInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
198224Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9c6c8815-50d8-4a3c-b348-98d5084c1408Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Spironolactone and hydrochlorothiazideSPIRONOLACTONE AND HYDROCHLOROTHIAZIDEAdvagen Pharma Ltd.9c6c8815-50d8-4a3c-b348-98d5084c14082026-09-11Warnings, Adverse reactionsExact identifier
application applno (ANDA): 220884
application number: ANDA220884
ndc (package): 72888-040-01
ndc (product): 72888-040
ndc11 (package): 72888004001

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
72888-040-017288800400130 TABLET in 1 BOTTLE (72888-040-01) 30 tablet2026-09-10NoNoCurrent